FATE THERAPEUTICS INC (FATE)
US31189P1021 - Common Stock
ChartMill assigns a Buy % Consensus number of 72% to FATE. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 7.96. This target is 66.1% above the current price.
FATE was analyzed by 26 analysts. The buy percentage consensus is at 72. So analysts seem to be have mildly positive about FATE.
In the previous month the buy percentage consensus was at a similar level.
FATE was analyzed by 26 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-11 | Needham | Reiterate | Hold |
| 2024-03-28 | B of A Securities | Maintains | Underperform -> Underperform |
| 2024-03-19 | HC Wainwright & Co. | Reiterate | Neutral |
| 2024-02-27 | BMO Capital | Maintains | Market Perform -> Market Perform |
| 2024-02-27 | Oppenheimer | Reiterate | Perform -> Perform |
| 2024-02-27 | Barclays | Maintains | Overweight -> Overweight |
| 2024-02-27 | Wedbush | Maintains | Neutral -> Neutral |
| 2024-02-27 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-11-20 | Mizuho | Maintains | Buy -> Buy |
| 2023-11-13 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-11-09 | BMO Capital | Maintains | Market Perform -> Market Perform |
| 2023-11-09 | Wedbush | Maintains | Neutral -> Neutral |
| 2023-11-09 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2023-09-07 | Cantor Fitzgerald | Reiterate | Neutral -> Neutral |
| 2023-08-16 | Truist Securities | Reiterate | Hold -> Hold |
| 2023-08-10 | Barclays | Maintains | Overweight -> Overweight |
| 2023-08-10 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-08-09 | EF Hutton | Reiterate | Buy -> Buy |
| 2023-08-09 | BMO Capital | Maintains | Market Perform -> Market Perform |
| 2023-05-05 | HC Wainwright & Co. | Reiterate | Neutral |
| 2023-05-04 | Cantor Fitzgerald | Maintains | Neutral |
| 2023-05-04 | Stifel | Maintains | Hold |
| 2023-03-02 | Citigroup | Maintains | Buy |
| 2023-03-01 | EF Hutton | Reiterate | Buy |
| 2023-01-24 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2023-01-09 | Goldman Sachs | Maintains | Sell |
| 2023-01-06 | EF Hutton | Maintains | Buy |
| 2023-01-06 | BMO Capital | Downgrade | Outperform -> Market Perform |
| 2023-01-06 | SVB Leerink | Maintains | Outperform |
| 2023-01-06 | Stifel | Downgrade | Buy -> Hold |